Menu
GeneBe

DUOX2

dual oxidase 2, the group of EF-hand domain containing

Basic information

Region (hg38): 15:45092649-45114172

Links

ENSG00000140279NCBI:50506OMIM:606759HGNC:13273Uniprot:Q9NRD8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • familial thyroid dyshormonogenesis (Supportive), mode of inheritance: AR
  • thyroid dyshormonogenesis 6 (Definitive), mode of inheritance: AR
  • thyroid dyshormonogenesis 6 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Thyroid dyshormonogenesis 6AD/AREndocrineIndividuals may manifest with congenital or subclinical hypothyroidism, and medical treatment (with thyroid hormone replacement) may be effectiveEndocrine12110737; 16134168; 21565790; 23239635; 23457309
Heterozygous variants have been reported as typically resulting in transient congenital hypothyroidism, while bi-allelic variants have been described as more frequently causing more severe and permanent forms of disease

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DUOX2 gene.

  • not provided (1178 variants)
  • Thyroid dyshormonogenesis 6 (279 variants)
  • Inborn genetic diseases (71 variants)
  • not specified (38 variants)
  • DUOX2-related condition (12 variants)
  • Congenital hypothyroidism (8 variants)
  • Nongoitrous Euthyroid Hyperthyrotropinemia (5 variants)
  • Familial thyroid dyshormonogenesis (2 variants)
  • See cases (2 variants)
  • Abnormal circulating thyroid hormone concentration (1 variants)
  • Meckel syndrome, type 11 (1 variants)
  • Idiopathic basal ganglia calcification 1 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DUOX2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
17
clinvar
204
clinvar
7
clinvar
228
missense
2
clinvar
6
clinvar
517
clinvar
30
clinvar
6
clinvar
561
nonsense
28
clinvar
11
clinvar
3
clinvar
42
start loss
0
frameshift
35
clinvar
16
clinvar
51
inframe indel
1
clinvar
10
clinvar
11
splice donor/acceptor (+/-2bp)
2
clinvar
24
clinvar
1
clinvar
27
splice region
37
32
2
71
non coding
40
clinvar
141
clinvar
63
clinvar
244
Total 68 57 588 375 76

Highest pathogenic variant AF is 0.000348

Variants in DUOX2

This is a list of pathogenic ClinVar variants found in the DUOX2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-45092712-C-T Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)888013
15-45092713-G-A Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)888014
15-45092722-C-T Thyroid dyshormonogenesis 6 Uncertain significance (Jan 15, 2018)888015
15-45092793-T-C Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)316120
15-45092798-C-T Thyroid dyshormonogenesis 6 Uncertain significance (Jan 12, 2018)888016
15-45092835-T-G Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)316121
15-45092906-A-T Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)316122
15-45092920-G-A Thyroid dyshormonogenesis 6 Uncertain significance (Jan 12, 2018)316123
15-45092947-G-A Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)884888
15-45093005-G-A Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)884889
15-45093086-C-T Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)884890
15-45093236-C-A Thyroid dyshormonogenesis 6 Uncertain significance (Jan 12, 2018)316124
15-45093293-C-T Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)884891
15-45093298-A-T Thyroid dyshormonogenesis 6 Benign (Jan 13, 2018)316125
15-45093372-G-T Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)885810
15-45093385-G-A Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)885811
15-45093428-C-T Thyroid dyshormonogenesis 6 Benign (Jan 12, 2018)316126
15-45093485-C-T Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)885812
15-45093526-G-A Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)316127
15-45093559-G-A Thyroid dyshormonogenesis 6 Likely benign (Jan 12, 2018)885813
15-45093565-T-C Thyroid dyshormonogenesis 6 Uncertain significance (Jan 12, 2018)885814
15-45093672-C-T Thyroid dyshormonogenesis 6 Benign (Jan 13, 2018)316128
15-45093675-C-T Thyroid dyshormonogenesis 6 Uncertain significance (Jan 13, 2018)886815
15-45093697-A-G Thyroid dyshormonogenesis 6 Benign (Jan 13, 2018)316129
15-45093718-C-T Thyroid dyshormonogenesis 6 Benign (Jan 13, 2018)316130

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DUOX2protein_codingprotein_codingENST00000603300 3321695
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.50e-561.07e-9124411913281257480.00533
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.179508541.110.000052910017
Missense in Polyphen386355.531.08574215
Synonymous-1.593873491.110.00002063117
Loss of Function-0.4648277.61.060.00000431848

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.005780.00576
Ashkenazi Jewish0.0007970.000794
East Asian0.01500.0148
Finnish0.01180.0118
European (Non-Finnish)0.004670.00462
Middle Eastern0.01500.0148
South Asian0.003280.00321
Other0.004410.00441

dbNSFP

Source: dbNSFP

Function
FUNCTION: Generates hydrogen peroxide which is required for the activity of thyroid peroxidase/TPO and lactoperoxidase/LPO. Plays a role in thyroid hormones synthesis and lactoperoxidase-mediated antimicrobial defense at the surface of mucosa. May have its own peroxidase activity through its N-terminal peroxidase-like domain. {ECO:0000269|PubMed:12824283}.;
Disease
DISEASE: Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200]: A disorder due to a defective conversion of accumulated iodide to organically bound iodine. The iodide organification defect can be partial or complete. {ECO:0000269|PubMed:12110737, ECO:0000269|PubMed:16134168, ECO:0000269|PubMed:16322276, ECO:0000269|PubMed:20187165}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in DUOX2 may play a role in the pathogenesis of very early onset inflammatory bowel disease (VEOIBD), a chronic, relapsing inflammation of the gastrointestinal tract with a complex etiology diagnosed before 6 years of age. VEOIBD is subdivided into Crohn disease and ulcerative colitis phenotypes. Crohn disease may affect any part of the gastrointestinal tract from the mouth to the anus, but the phenotype of children with onset of Crohn disease occurring younger than the age of 10 is predominantly colonic, with a lower risk of ileal disease. Bowel inflammation is transmural and discontinuous; it may contain granulomas or be associated with intestinal or perianal fistulas. In contrast, in ulcerative colitis, the inflammation is continuous and limited to rectal and colonic mucosal layers; fistulas and granulomas are not observed. Both diseases include extraintestinal inflammation of the skin, eyes, or joints. {ECO:0000269|PubMed:26301257}.;
Pathway
Thyroid hormone synthesis - Homo sapiens (human);Thyroid hormone synthesis;Nucleotide-binding Oligomerization Domain (NOD) pathway;Metabolism of amino acids and derivatives;Metabolism;Thyroxine biosynthesis;Amine-derived hormones (Consensus)

Recessive Scores

pRec
0.215

Intolerance Scores

loftool
0.135
rvis_EVS
0.23
rvis_percentile_EVS
68.52

Haploinsufficiency Scores

pHI
0.151
hipred
N
hipred_score
0.241
ghis
0.433

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
N
gene_indispensability_score
0.474

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Duox2
Phenotype
endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype;

Zebrafish Information Network

Gene name
duox
Affected structure
neutrophil
Phenotype tag
abnormal
Phenotype quality
decreased process quality

Gene ontology

Biological process
thyroid hormone generation;defense response;response to oxidative stress;fertilization;response to virus;cytokine-mediated signaling pathway;bone mineralization;thyroid gland development;multicellular organism growth;cuticle development;hormone biosynthetic process;superoxide anion generation;hydrogen peroxide catabolic process;inner ear development;adenohypophysis morphogenesis;hydrogen peroxide biosynthetic process;response to cAMP;oxidation-reduction process;positive regulation of wound healing;cellular oxidant detoxification;positive regulation of cell motility
Cellular component
endoplasmic reticulum;cytosol;plasma membrane;cell surface;integral component of membrane;apical plasma membrane;cell junction;cell leading edge;NADPH oxidase complex;apical part of cell;extracellular exosome
Molecular function
peroxidase activity;calcium ion binding;protein binding;NAD(P)H oxidase activity;superoxide-generating NADPH oxidase activity;heme binding